Bisindolylmaleimide I

TargetMol
Product Code: TAR-T6513
Supplier: TargetMol
CodeSizePrice
TAR-T6513-5mg5mg£119.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6513-1mL1 mL * 10 mM (in DMSO)£124.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6513-10mg10mg£152.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6513-25mg25mg£230.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6513-50mg50mg£367.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6513-100mg100mg£466.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
GF109203X is a potent and highly selective protein kinase C (PKC) inhibitor with a Ki of 14 nM.
CAS:
133052-90-1
Formula:
C25H24N4O2
Molecular Weight:
412.493
Pathway:
Chromatin/Epigenetic; Tyrosine Kinase/Adaptors; Angiogenesis; Cytoskeletal Signaling
Purity:
0.9908
SMILES:
CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c2c[nH]c3ccccc23)c2ccccc12
Target:
PDGFR; PKC

References

Gekeler V, et al. Biochem Biophys Res Commun. 1995, 206(1), 119-126. Park YS, et al. Mol Cell Biochem. 2012, 370(1-2), 191-198. Vetri F, et al. Impairment of neurovascular coupling in Type 1 Diabetes Mellitus in rats is prevented by pancreatic islet transplantation and reversed by a semi-selective PKC inhibitor. Brain Res. 2017 Jan 15;1655:48-54. Souza AL, et al. Br J Pharmacol. 2002, 135(1), 239-247. Toullec D, et al. J Biol Chem. 1991, 266(24), 15771-15781. Gekeler V, et al. Br J Cancer. 1996, 74(6), 897-905. Zheng Q, Zou Y, Teng P, et al. Mechanosensitive Channel PIEZO1 Senses Shear Force to Induce KLF2/4 Expression via CaMKII/MEKK3/ERK5 Axis in Endothelial Cells. Cells. 2022, 11(14): 2191